Kissei Pharmaceutical Co., Ltd.

66
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,585.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
21.00
18.00
20.00
23.00
23.00
23.00
General and Administration Expenses
38,291.00
20,790.00
20,304.00
19,923.00
19,607.00
21,133.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
82,556.00
71,419.00
68,487.00
66,646.00
67,389.00
61,225.00
Operating Profit (PBDIT) excl Other Income
5,774.00
4,160.00
-994.00
-1,265.00
1,655.00
2,020.00
Other Income
13,064.00
10,143.00
14,777.00
18,373.00
5,347.00
3,599.00
Operating Profit (PBDIT)
23,453.00
18,414.00
17,743.00
20,701.00
10,001.00
8,018.00
Interest
21.00
18.00
20.00
23.00
23.00
23.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
4,615.00
4,254.00
4,109.00
3,730.00
3,148.00
2,562.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
4,630.00
Provision for Tax
3,634.00
3,159.00
3,046.00
3,475.00
2,098.00
1,741.00
Profit After Tax
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
274.20
246.58
228.30
280.19
113.25
60.30
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 38.80% vs 518.51% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 7.17% vs 6.00% in Mar 2024

Compare Profit and Loss Results of Kissei Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
88,330.00
47,618.00
40,712.00
85.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
88,330.00
47,618.00
40,712.00
85.50%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
21.00
478.00
-457.00
-95.61%
General and Administration Expenses
38,291.00
28,856.00
9,435.00
32.70%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
82,556.00
47,316.00
35,240.00
74.48%
Operating Profit (PBDIT) excl Other Income
5,774.00
302.00
5,472.00
1,811.92%
Other Income
13,064.00
989.00
12,075.00
1,220.93%
Operating Profit (PBDIT)
23,453.00
4,889.00
18,564.00
379.71%
Interest
21.00
478.00
-457.00
-95.61%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
4,615.00
3,598.00
1,017.00
28.27%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15,610.00
-305.00
15,915.00
5,218.03%
Provision for Tax
3,634.00
-71.00
3,705.00
5,218.31%
Profit After Tax
11,961.00
-650.00
12,611.00
1,940.15%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
274.1973
-4.8393
279.04
5,766.05%
Profit And Loss - Net Sales
Net Sales 88,330.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,774.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 38.80% vs 518.51% in Mar 2024

Profit And Loss - Interest
Interest 21.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 11,961.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 7.17% vs 6.00% in Mar 2024